AstraZeneca agrees to make COVID-19 vaccine for Europe
Pharma giant AstraZeneca struck a deal Saturday with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental COVID-19 vaccine, as efforts to boost manufacturing capacity continue at pace.
0 comments:
Post a Comment